NEW YORK, Oct. 17, 2016 (GLOBE NEWSWIRE) -- The Academy of Allergy and Asthma in Primary Care (AAAPC) will host a live educational webinar on Monday, October 24 from 1:00 p.m. – 2:00 p.m. ET about "The Safety of SCIT-Based Allergen-Immunotherapy." The webinar will be presented by allergist-immunologist Dr. Frederick Schaffer, who will discuss safe practices when it comes to subcutaneous immunotherapy (SCIT) and related morbidity and mortality risks, as well as how to minimize these risks in patients. A question-and-answer session will immediately follow the presentation.
Attendees will gain an understanding not only of safe practices, but of safe patient selection, as well as a delineation of therapeutic-based risks in order to best assess and treat patients with allergic disorders while facilitating long term patient safety. As a result, attendees are able to fulfill AMA PRA Credits for learning patient selection, how to minimize morbidity and how to promote safety based compliance for patients on SCIT.
- Determine who is an appropriate patient for safe diagnostic assessment and treatment
- Discuss the safety profile of several therapeutic regimens discussed
- Describe how adverse events, safety, and compliance determination impact the efficacy of therapy
- Utilize safety assessment tools to utilize throughout the 3 year course of SCIT therapy
WHAT: "The Safety of SCIT-Based Allergen-Immunotherapy"
WHEN: Monday, October 24, 2016, 1:00 p.m. ET
REGISTER: For details and registration, visit https://www.aaapc.org/i4a/pages/index.cfm?pageID=3352
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Amedco and AAAPC. Amdeco is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
Amedco designates this live activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Academy of Allergy and Asthma in Primary Care (AAAPC) is a national non-profit organization, which supports innovative care models of allergy and asthma care in the primary care setting and assists physicians in expanding their role to provide allergy diagnostics and therapy to the under-served patient population. AAAPC is a voice for thousands of physicians and patients using allergy and asthma diagnostic and therapeutic services to raise awareness of the link between allergy care and asthma prevention, particularly in pediatric and family practice populations.
The mission of the Academy of Allergy & Asthma in Primary Care is to foster the ability of physicians to provide high quality, accessible patient diagnostic and therapeutic allergy and asthma care.
CONTACT: Kristen Kurtz T: 917-561-2406 E: email@example.comSource:The Academy of Allergy and Asthmain Primary Care